A state of the “heart”: application of bioengineered materials for cardiac surgery
DOI:
https://doi.org/10.12775/JEHS.2020.10.09.113Keywords
cardiovascular disease, cardiovascular biomaterials, decellularization, xenogenous valvesAbstract
Introduction. Cardiovascular diseases have become the leading mortality cause, requiring a novel technologies and techniques for the treatment. Cardiovascular biomaterials play a vital role as the potentially eligible alternative modality for an operation, covering the gap between facilities and patients in need of medical devices and procedures.
Purpose. The aim of this essay is to explore and analyze the currently used biomaterials for cardiac surgery as tools to repair or replace the damaged tissues. This study seeks to obtain data which will help to address research gaps and to stimuli the manufacturing process.
Description of the state of knowledge. We conduct the systematic literature review, based on the information found in PubMed, Research Gate and Google Scholar databases using the eligible parameters. Obtained data in form of descriptive information were analyzed.
Summary. This study has identified a wide area of cardiovascular biomaterials use in the modern clinical and scientific practice. The most obvious finding to emerge from this study is that decellularization of xenogenous heart valves is a crucial feature to obtain the optimal matrix for a tissue-engineered valve substitute. This information can be used to develop targetted interventions aimed at cardiac surgery.
References
Gaziano T, Reddy KS, Paccaud F, et al. Cardiovascular Disease. In: Jamison DT, Breman JG, Measham AR, et al., editors. Disease Control Priorities in Developing Countries. 2nd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2006. Chapter 33
Mc Namara K, Alzubaidi H, Jackson JK. Cardiovascular disease as a leading cause of death: how are pharmacists getting involved?. Integr Pharm Res Pract. 2019;8:1-11. Published 2019 Feb 4. doi:10.2147/IPRP.S133088.
Gelchu T, Abdela J. Drug therapy problems among patients with cardiovascular disease admitted to the medical ward and had a follow-up at the ambulatory clinic of Hiwot Fana Specialized University Hospital: The case of a tertiary hospital in eastern Ethiopia. SAGE Open Med. 2019;7:2050312119860401. Published 2019 Jul 18. doi:10.1177/2050312119860401
Panagiotis Mallis, Efstathios Michalopoulos, Constantine Dimitriou, Nikolaos Kostomitsopoulos and Catherine Stavropoulos-Giokas. Histological and biomechanical characterization of decellularized porcine pericardium. Bio-Medical Materials and Engineering 28 (2017), 477–488.
Chen FM, Liu X. Advancing biomaterials of human origin for tissue engineering. Prog Polym Sci. 2016;53:86-168. doi:10.1016/j.progpolymsci.2015.02.004
Jaganathan SK, Supriyanto E, Murugesan S, Balaji A, Asokan MK. Biomaterials in cardiovascular research: applications and clinical implications. Biomed Res Int. 2014;2014:459465. doi:10.1155/2014/459465
Williams, D. F., ed., “Definitions in biomaterials,” Progress in Biomedical Engineering 4:67 (1987)
Curtis MW, Russell B. Cardiac tissue engineering. J Cardiovasc Nurs. 2009;24(2):87-92. doi:10.1097/01.JCN.0000343562.06614.49
Peters B, Ewert P, Berger F. The role of stents in the treatment of congenital heart disease: Current status and future perspectives. Ann Pediatr Cardiol. 2009;2(1):3-23. doi:10.4103/0974-2069.52802
J.P. Binet, A. Carpentier, J. Langlois, C. Duran, P. Colvez Implantation of heterogenic valves in the treatment of aortic cardiopathies C. R. Acad. Sci. Hebd. Seances Acad. Sci. D., 261 (1965), pp. 5733-5734
Lopez-Moya M, Melgar-Lesmes P, Kolandaivelu K, de la Torre Hernández JM, Edelman ER, Balcells M. Optimizing Glutaraldehyde-Fixed Tissue Heart Valves with Chondroitin Sulfate Hydrogel for Endothelialization and Shielding against Deterioration. Biomacromolecules. 2018;19(4):1234-1244. doi:10.1021/acs.biomac.8b00077
Collatusso, Claudinei & Roderjan, João Gabriel & Vieira, Eduardo & Myague, Nelson & Noronha, Lúcia & Costa, Francisco. (2011). Decellularization as an anticalcification method in stentless bovine pericardium valve prosthesis: A study in sheep. Revista brasileira de cirurgia cardiovascular : órgão oficial da Sociedade Brasileira de Cirurgia Cardiovascular. 26. 419-26. 10.5935/1678-9741.20110017.
Gilpin A, Yang Y. Decellularization Strategies for Regenerative Medicine: From Processing Techniques to Applications. Biomed Res Int. 2017;2017:9831534. doi:10.1155/2017/9831534
Wollmann L, Suss P, Mendonça J, Luzia C, Schittini A, Rosa GW. Caracterização do Pericárdio Humano Descelularizado para Engenharia de Tecidos e Aplicações de Medicina Regenerativa. Arq Bras Cardiol. 2019;113(1):11–17
Lima EO, Ferrasi AC, Kaasi A. Decellularization of Human Pericardium with Potential Application in Regenerative Medicine. Arq Bras Cardiol. 2019;113(1):18-19. Published 2019 Aug 8. doi:10.5935/abc.20190130
Wilcox,H.E.;Watterson,K.G.;Kearney,J.N.;Hunt,J.;Fisher,J.;Ingham,E.Biocompatibility of acellular human pericardium. J. Surg. Res. 2007, 143, 407–414.
Rajabi-Zeleti, S.; Jalili-Firoozinezhad, S.; Azarnia, M.; Khayyatan, F.; Vahdat, S.; Nikeghbalian, S.; Khademhosseini, A.; Baharvand, H.; Aghdami, N. The behavior of cardiac progenitor cells on macroporous pericardium-derived scaffolds. Biomaterials 2014, 35, 970–982.
Van Steenberghe, M.; Schubert, T.; Guiot, Y.; Bouzin, C.; Bollen, X.; Gianello, P. Enhanced vascular biocompatibility of decellularized xeno-/allogeneic matrices in a rodent model. Cell Tissue Bank. 2017, 18, 249–262.
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 525
Number of citations: 0
